Table 5. Overview of retrospective analyses on extremity STS.
Excluded low‐grade tumors.
Value for 5‐year OS.
Also included non‐extremity sites; 848 extremity STS were assessed.
Abbreviations: 5‐DSS, disease‐specific survival at 5 years; 5‐LRFS, local recurrence‐free survival rate at 5 years; 5‐MFS, metastasis‐free survival at 5 years; FU, follow‐up; OS, overall survival; NA, data not available; STS, soft tissue sarcomas.